Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Sep 16;75(9):e30-e33.
doi: 10.1093/gerona/glaa094.

A Geroscience Perspective on COVID-19 Mortality

Affiliations

A Geroscience Perspective on COVID-19 Mortality

Daniel E L Promislow. J Gerontol A Biol Sci Med Sci. .

Abstract

A novel coronavirus, SARS-CoV-2, emerged in December 2019, leading within a few months to a global pandemic. COVID-19, the disease caused by this highly contagious virus, can have serious health consequences, though risks of complications are highly age-dependent. Rates of hospitalization and death are less than 0.1% in children, but increase to 10% or more in older people. Moreover, at all ages, men are more likely than women to suffer serious consequences from COVID-19. These patterns are familiar to the geroscience community. The effects of age and sex on mortality rates from COVID-19 mirror the effects of aging on almost all major causes of mortality. These similarities are explored here, and underscore the need to consider the role of basic biological mechanisms of aging on potential treatment and outcomes of COVID-19.

Keywords: Biology of aging; COVID-19; Immunosenescence; Mortality; SARS-CoV-2.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Age-related risk of death from COVID-19. (A) Case fatality rate for COVID-19 in China and Italy, plotted on an absolute scale. (B) Case fatality rate for COVID-19 in China and Italy, plotted on a log10 scale. Straight lines represent fitted values from least-squares fitted regression from ages 20–70. (C) Deaths per 100,000 from COVID-19 in New York City plotted on an absolute scale. (D) Deaths per 100,000 from COVID-19 in New York City plotted on a log10 scale. The straight line is the fitted linear regression.
Figure 2.
Figure 2.
Age-related risk of mortality from multiple causes. (A) Deaths per 100,000 from specific causes, as well as all-cause mortality, for both sexes in the United States, 2017. (B) Deaths per 100,000 from specific causes and all-cause mortality, plotted on a log10 scale. The numbers in the legend refer to the mortality rate doubling time (MRDT). The dotted line is deaths per 100,000 from COVID-19 in New York City. The New York City MRDT = 9.0 years (95% confidence interval [CI] = 6.6–13.9). For specific causes of mortality, MRDT 95% CI: all causes (8.6–9.1); heart disease (6.4–7.6); malignant neoplasms (5.7–7.0); Chronic obstructive pulmonary disease (COPD) (4.5–5.0); diabetes (6.7–7.5); and kidney disease (6.4–6.7).
Figure 3.
Figure 3.
Sex-differences in age-related mortality. (A) Age-specific deaths per 100,000 population in the United States in 2017 for males (blue) and females (red). (B) Age-specific case fatality rate for COVID-19 for men (blue) and women (red) in Italy in 2020.

References

    1. Coronavirus Resource Center, Johns Hopkins University. https://coronavirus.jhu.edu/; 2020. Accessed April 2, 2020.
    1. Shim E, Tariq A, Choi W, Lee Y, Chowell G. Transmission potential and severity of COVID-19 in South Korea. Int J Infect Dis. 2020;93:339–344. doi: 10.1016/j.ijid.2020.03.031 - DOI - PMC - PubMed
    1. Verity R, Okell LC, Dorigatti I, et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis [published online ahead of print April 28, 2020]. Lancet Infect Dis. 2020. doi: 10.1016/S1473-3099(20)30257-7 - DOI - PMC - PubMed
    1. Istituto Superiore di Sanità R. Epidemia COVID-19. https://www.epicentro.iss.it/coronavirus/bollettino/Bollettino-sorveglia...; 2020. Accessed April 2, 2020.
    1. Le Couteur DG, Anderson RM, Newman AB. COVID-19 through the lens of gerontology. J Gerontol A Biol Sci Med Sci. 2020.doi: 10.1093/gerona/glaa077. - DOI - PMC - PubMed

Publication types